Jul 17, 2026 05:31PM
Apr 10, 2026 05:30PM
Feb 19, 2026 05:29PM
Feb 2, 2026 05:30PM
Dec 30, 2025 06:03AM
Aug 19, 2025 08:30AM
Aug 19, 2025 08:30AM Propanc Biopharma Announces Closing of Public Offering and Uplisting to NASDAQ
Jul 28, 2025 05:13PM
May 30, 2025 03:40PM
Apr 25, 2025 02:45PM
Apr 8, 2025 05:32PM
Apr 2, 2025 05:27PM
Mar 31, 2025 06:20AM
Oct 30, 2024 06:46AM Form S-1 Propanc Biopharma, Inc.
Oct 10, 2023 06:43AM
Oct 6, 2023 05:27PM
Aug 11, 2023 05:21PM
Jun 22, 2023 09:00AM
Feb 10, 2022 11:18AM
Feb 3, 2022 04:22PM
Dec 14, 2021 09:00AM Propanc Biopharma Enters into $5 Million Equity Purchase Facility with Dutchess Capital Growth Fund LP
Nov 3, 2021 09:00AM
May 17, 2021 09:00AM
Mar 25, 2021 09:00AM
Mar 3, 2021 09:00AM
Feb 15, 2021 09:00AM
Jan 28, 2021 09:00AM
Jan 18, 2021 08:30AM Propanc Biopharma Receives Expression of Interest to Evaluate Proenzyme Therapy in Pancreatic and Ovarian Cancer Patients
Jan 11, 2021 08:30AM
Dec 21, 2020 08:30AM
Dec 14, 2020 08:30AM
Nov 3, 2020 05:09PM
Oct 14, 2020 06:03AM
Aug 13, 2020 08:14AM
Jul 28, 2020 08:30AM Propanc Biopharma Receives Investment from Institutional Investor
Jul 17, 2020 06:04AM
Jun 26, 2020 05:31PM
May 13, 2020 05:51PM
May 11, 2020 08:30AM
Apr 16, 2020 08:30AM
Apr 14, 2020 09:00AM
Mar 31, 2020 09:00AM Propanc Biopharma Enters Into a $3 Million Financing with Institutional Investor
Mar 16, 2020 08:30AM
Jan 24, 2020 05:12PM
Jan 21, 2020 08:30AM
Dec 12, 2019 05:50PM
Nov 18, 2019 08:30AM
Oct 29, 2019 08:30AM
Oct 21, 2019 08:30AM Propanc Biopharma Illustrates Novel Mode of Action of PRP, Suppressing EMT Pathways and Metastasis in Cancer Patients
Aug 21, 2019 08:41AM

67,805 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All